Recall of Fasenra Pen 30 mg/mL Batch
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Fasenra pen 30MG/ML Benralizumab 0212222960 YK0060 AstraZeneca Pharmaceuticals LP
التصنيف
ملف
التاريخ
2025-12-29
اسم المستحضر
Fasenra pen 30MG/ML
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The Saudi Food and Drug Authority (SFDA) has issued a recall for one batch of the Fasenra Pen 30 mg/mL product due to its non-compliance with the approved product specifications.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.